View Financial HealthCanadian Phosphate 배당 및 자사주 매입배당 기준 점검 0/6Canadian Phosphate 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-4.7%자사주 매입 수익률총 주주 수익률-4.7%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Jun 28New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 27% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (35% average weekly change). Minor Risks Shareholders have been diluted in the past year (27% increase in shares outstanding). Revenue is less than US$5m (AU$2.3m revenue, or US$1.6m). Market cap is less than US$100m (AU$46.6m market cap, or US$32.2m).공고 • Jun 01+ 1 more updateCanadian Phosphate Limited (ASX:CP8) agreed to acquire Diamond Mountain from Revival Gold Inc. (TSXV:RVG) and Utah Mineral Resources, LLC for $3 million.Canadian Phosphate Limited (ASX:CP8) agreed to acquire Diamond Mountain from Revival Gold Inc. (TSXV:RVG) and Utah Mineral Resources, LLC for $3 million on May 29, 2026. The consideration includes Cash payment of $750,000 with $250,000 due on closing date and the remaining $500,000 due on the first 12-month anniversary and Issuance of CP8 shares of $750,000 in value, being 6,041,737 CP8 shares with a deemed issue price of AUD$0.1743 per CP8 share. 50% of the shares are restricted from trading for a period of 12 months and the remaining 50% of shares are restricted from trading for a period of 24 months and Deferred consideration of $1.5 million payable in cash or shares (at CP8’s election) on or prior to the first anniversary of the commencement of commercial production.Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Peter Doyle was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • May 01No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non- Executive Director Malcolm Weber was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Mar 19Canadian Phosphate Limited, Annual General Meeting, May 28, 2026Canadian Phosphate Limited, Annual General Meeting, May 28, 2026.공고 • Dec 12Canadian Phosphate Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million.Canadian Phosphate Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 40,000,000 Price\Range: AUD 0.05 Discount Per Security: AUD 0.003 Transaction Features: Subsequent Direct Listing공고 • Mar 18Canadian Phosphate Limited, Annual General Meeting, May 29, 2025Canadian Phosphate Limited, Annual General Meeting, May 29, 2025.Board Change • Dec 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non- Executive Director Malcolm Weber was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Sep 05No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non- Executive Director Malcolm Weber was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Apr 28Fertoz Limited, Annual General Meeting, May 29, 2024Fertoz Limited, Annual General Meeting, May 29, 2024, at 10:01 E. Australia Standard Time. Location: Level 5, 126 Phillip Street Sydney Nsw 2000 Australia Agenda: To consider Adoption of Remuneration Report; to Election of Greg West as Director; to consider Ratification of Prior Issue of Convertible Notes; to consider Approval to Increase the Maximum Aggregate Amount of Non-Executive Directors' Fees; to consider Ratification of Appointment of Auditor; and to consider other matters.Board Change • Apr 04No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Feb 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Dec 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • Nov 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$15.0m (US$9.94m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.5m free cash flow). Shares are highly illiquid. Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (AU$15.0m market cap, or US$9.94m). Minor Risk Revenue is less than US$5m (AU$3.4m revenue, or US$2.3m).공고 • Oct 12Fertoz Limited Announces Executive ChangesFertoz Limited advised, in accordance with ASX Listing Rule 3.16.1, that Ms Leah Pieris from the Automic Group has been appointed as Joint Company Secretary of the Company, with effect from October 12, 2023. Ms Pieris is a Chartered Company Secretary. Ms Pieris is a member of Automic Group, which provides market leading, cloud-based share registry technology, compliance and governance solutions, supported by a tailored range of professional services. As a member of Automic Group's Company Secretary team, Ms Pieris assists ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Nova Taylor will step down as Company Secretary of the Company October 12, 2023. For the purpose of ASX Listing Rule 12.6, Mr. Max Crowley and Ms Leah Pieris will be the people responsible for communications between the Company and ASX.Board Change • Sep 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Aug 03No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Jul 13Fertoz Limited Announces Change of Chief Financial OfficerFertoz Limited advised of the appointment of Ben Bussell as Global Chief Financial Officer of the Company effective 13 July 2023. Mr. Bussell has been a consultant of the Company since April 2023. Mr. Bussell is a Senior Accountant with over 19 years' experience in public accounting, corporate accounting and taxation and a member of the Governance Institute of Australia. Mr. Bussell is currently the Chief Financial Officer of several other ASX- listed and private entities. Mr. Bussell has also previously been a non-executive director of several ASX-listed companies including Auroch Minerals NL, SWW Energy Ltd. and White Eagle Resources Ltd. Further to this appointment, Emma Davidson will step down as Chief Financial Officer of the Company effective 13 July 2023 and will continue with the Company as its North American Accountant.공고 • May 06Fertoz Limited Announces Resignation of Patrick Avery as Non-Executive DirectorFertoz Limited advised Mr. Patrick Avery has resigned as Non-Executive Director, to pursue other opportunities, effective 5 May 2023.공고 • Feb 11Fertoz Ltd Announces Patrick Avery Will Step Down as Executive DirectorFertoz Ltd. Announced that Mr. Patrick Avery will step down as Executive Director of the Company but will remain on the Board as a Non-Executive Director, effective 10 February 2023. Mr. Avery's decision to step down follows the appointment of Daniel Gleeson as Managing Director and CEO of the Group and Stuart Richardson's appointment as Chairman last year as the Company expands its leadership skillset and positions itself to meet growing demand for regenerative farm inputs. From 10 February 2023, Mr. Avery will receive Non-Executive Director fees paid out of the non-executive director remuneration pool approved by shareholders. In accordance with Listing Rule 3.16.4, Fertoz confirms that the Executive Consultancy Agreement between LDR Solutions LLC and Fertoz Limited, under which Mr. Avery provided services to Fertoz, has been amended to reflect the abovementioned change.Board Change • Nov 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Greg West was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Sep 15First half 2022 earnings released: AU$0.009 loss per share (vs AU$0.003 loss in 1H 2021)First half 2022 results: AU$0.009 loss per share (further deteriorated from AU$0.003 loss in 1H 2021). Revenue: AU$1.92m (up 67% from 1H 2021). Net loss: AU$2.16m (loss widened 274% from 1H 2021).Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Greg West was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 02Full year 2021 earnings released: AU$0.019 loss per share (vs AU$0.01 loss in FY 2020)Full year 2021 results: AU$0.019 loss per share (down from AU$0.01 loss in FY 2020). Revenue: AU$2.24m (up 10% from FY 2020). Net loss: AU$3.75m (loss widened 144% from FY 2020). Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 9% per year.Reported Earnings • Sep 15First half 2021 earnings released: AU$0.003 loss per share (vs AU$0.005 loss in 1H 2020)The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: AU$1.15m (up 24% from 1H 2020). Net loss: AU$576.9k (loss narrowed 22% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 26% per year.Recent Insider Transactions • Jul 02Insider recently bought AU$1.2m worth of stockOn the 23rd of June, Bernanrd Stephens bought around 10m shares on-market at roughly AU$0.12 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.3m more in shares than they have sold in the last 12 months.Reported Earnings • Apr 01Full year 2020 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2019)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: AU$2.04m (up 53% from FY 2019). Net loss: AU$1.54m (loss narrowed 15% from FY 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 CP8 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: CP8 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Canadian Phosphate 배당 수익률 vs 시장CP8의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (CP8)n/a시장 하위 25% (AU)2.7%시장 상위 25% (AU)6.6%업계 평균 (Chemicals)2.0%분석가 예측 (CP8) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 CP8 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 CP8 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 CP8 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: CP8 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YAU 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/24 22:04종가2026/07/23 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Canadian Phosphate Limited는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullIndependent Investment Research (Aust.) Pty Ltd
New Risk • Jun 28New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 27% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (35% average weekly change). Minor Risks Shareholders have been diluted in the past year (27% increase in shares outstanding). Revenue is less than US$5m (AU$2.3m revenue, or US$1.6m). Market cap is less than US$100m (AU$46.6m market cap, or US$32.2m).
공고 • Jun 01+ 1 more updateCanadian Phosphate Limited (ASX:CP8) agreed to acquire Diamond Mountain from Revival Gold Inc. (TSXV:RVG) and Utah Mineral Resources, LLC for $3 million.Canadian Phosphate Limited (ASX:CP8) agreed to acquire Diamond Mountain from Revival Gold Inc. (TSXV:RVG) and Utah Mineral Resources, LLC for $3 million on May 29, 2026. The consideration includes Cash payment of $750,000 with $250,000 due on closing date and the remaining $500,000 due on the first 12-month anniversary and Issuance of CP8 shares of $750,000 in value, being 6,041,737 CP8 shares with a deemed issue price of AUD$0.1743 per CP8 share. 50% of the shares are restricted from trading for a period of 12 months and the remaining 50% of shares are restricted from trading for a period of 24 months and Deferred consideration of $1.5 million payable in cash or shares (at CP8’s election) on or prior to the first anniversary of the commencement of commercial production.
Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Non-Executive Director Peter Doyle was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • May 01No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non- Executive Director Malcolm Weber was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Mar 19Canadian Phosphate Limited, Annual General Meeting, May 28, 2026Canadian Phosphate Limited, Annual General Meeting, May 28, 2026.
공고 • Dec 12Canadian Phosphate Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million.Canadian Phosphate Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 40,000,000 Price\Range: AUD 0.05 Discount Per Security: AUD 0.003 Transaction Features: Subsequent Direct Listing
공고 • Mar 18Canadian Phosphate Limited, Annual General Meeting, May 29, 2025Canadian Phosphate Limited, Annual General Meeting, May 29, 2025.
Board Change • Dec 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non- Executive Director Malcolm Weber was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Sep 05No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non- Executive Director Malcolm Weber was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Apr 28Fertoz Limited, Annual General Meeting, May 29, 2024Fertoz Limited, Annual General Meeting, May 29, 2024, at 10:01 E. Australia Standard Time. Location: Level 5, 126 Phillip Street Sydney Nsw 2000 Australia Agenda: To consider Adoption of Remuneration Report; to Election of Greg West as Director; to consider Ratification of Prior Issue of Convertible Notes; to consider Approval to Increase the Maximum Aggregate Amount of Non-Executive Directors' Fees; to consider Ratification of Appointment of Auditor; and to consider other matters.
Board Change • Apr 04No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Feb 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Dec 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • Nov 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$15.0m (US$9.94m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.5m free cash flow). Shares are highly illiquid. Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (AU$15.0m market cap, or US$9.94m). Minor Risk Revenue is less than US$5m (AU$3.4m revenue, or US$2.3m).
공고 • Oct 12Fertoz Limited Announces Executive ChangesFertoz Limited advised, in accordance with ASX Listing Rule 3.16.1, that Ms Leah Pieris from the Automic Group has been appointed as Joint Company Secretary of the Company, with effect from October 12, 2023. Ms Pieris is a Chartered Company Secretary. Ms Pieris is a member of Automic Group, which provides market leading, cloud-based share registry technology, compliance and governance solutions, supported by a tailored range of professional services. As a member of Automic Group's Company Secretary team, Ms Pieris assists ASX listed, unlisted public and proprietary companies across a range of industries. Further to this appointment, Ms Nova Taylor will step down as Company Secretary of the Company October 12, 2023. For the purpose of ASX Listing Rule 12.6, Mr. Max Crowley and Ms Leah Pieris will be the people responsible for communications between the Company and ASX.
Board Change • Sep 28No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Aug 03No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Group CEO, MD & Director Daniel Gleeson was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Jul 13Fertoz Limited Announces Change of Chief Financial OfficerFertoz Limited advised of the appointment of Ben Bussell as Global Chief Financial Officer of the Company effective 13 July 2023. Mr. Bussell has been a consultant of the Company since April 2023. Mr. Bussell is a Senior Accountant with over 19 years' experience in public accounting, corporate accounting and taxation and a member of the Governance Institute of Australia. Mr. Bussell is currently the Chief Financial Officer of several other ASX- listed and private entities. Mr. Bussell has also previously been a non-executive director of several ASX-listed companies including Auroch Minerals NL, SWW Energy Ltd. and White Eagle Resources Ltd. Further to this appointment, Emma Davidson will step down as Chief Financial Officer of the Company effective 13 July 2023 and will continue with the Company as its North American Accountant.
공고 • May 06Fertoz Limited Announces Resignation of Patrick Avery as Non-Executive DirectorFertoz Limited advised Mr. Patrick Avery has resigned as Non-Executive Director, to pursue other opportunities, effective 5 May 2023.
공고 • Feb 11Fertoz Ltd Announces Patrick Avery Will Step Down as Executive DirectorFertoz Ltd. Announced that Mr. Patrick Avery will step down as Executive Director of the Company but will remain on the Board as a Non-Executive Director, effective 10 February 2023. Mr. Avery's decision to step down follows the appointment of Daniel Gleeson as Managing Director and CEO of the Group and Stuart Richardson's appointment as Chairman last year as the Company expands its leadership skillset and positions itself to meet growing demand for regenerative farm inputs. From 10 February 2023, Mr. Avery will receive Non-Executive Director fees paid out of the non-executive director remuneration pool approved by shareholders. In accordance with Listing Rule 3.16.4, Fertoz confirms that the Executive Consultancy Agreement between LDR Solutions LLC and Fertoz Limited, under which Mr. Avery provided services to Fertoz, has been amended to reflect the abovementioned change.
Board Change • Nov 18No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Greg West was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Sep 15First half 2022 earnings released: AU$0.009 loss per share (vs AU$0.003 loss in 1H 2021)First half 2022 results: AU$0.009 loss per share (further deteriorated from AU$0.003 loss in 1H 2021). Revenue: AU$1.92m (up 67% from 1H 2021). Net loss: AU$2.16m (loss widened 274% from 1H 2021).
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Greg West was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 02Full year 2021 earnings released: AU$0.019 loss per share (vs AU$0.01 loss in FY 2020)Full year 2021 results: AU$0.019 loss per share (down from AU$0.01 loss in FY 2020). Revenue: AU$2.24m (up 10% from FY 2020). Net loss: AU$3.75m (loss widened 144% from FY 2020). Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 9% per year.
Reported Earnings • Sep 15First half 2021 earnings released: AU$0.003 loss per share (vs AU$0.005 loss in 1H 2020)The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: AU$1.15m (up 24% from 1H 2020). Net loss: AU$576.9k (loss narrowed 22% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 26% per year.
Recent Insider Transactions • Jul 02Insider recently bought AU$1.2m worth of stockOn the 23rd of June, Bernanrd Stephens bought around 10m shares on-market at roughly AU$0.12 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.3m more in shares than they have sold in the last 12 months.
Reported Earnings • Apr 01Full year 2020 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2019)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: AU$2.04m (up 53% from FY 2019). Net loss: AU$1.54m (loss narrowed 15% from FY 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.